RxDoctor Payments Data

Jessica Drane

Nurse Practitioner · Albuquerque, NMNPI 1912443193

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Johnson & Johnson at 30.6% of the total. Reporting peaked in 2022 at $1,028 and has fallen 87.5% since, to $129 in 2024. Among nurse practitioner clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,578in general payments, 2019–2025

Across 25 payments — averaging $63.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$483
  • AstraZeneca$232
  • Nevro Corp.$142
  • Lilly USA, LLC$125
  • Althera Pharmaceuticals LLC$123
  • Paratek Pharmaceuticals, Inc.$117
  • plus $356 from 7 others

What the payments were for

  • Speaking & faculty fees$181%
  • Food & beverage$1,56099%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,578 in reported general payments places this provider in the 90th percentile of 624 nurse practitioner providers in New Mexico.

See all nurse practitioner providers in New Mexico

Medicare billing

Part B allowed, 2024
$63,752
Medicare patients
321
Services billed
803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefdinir11$235
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$156
Pantoprazole Sodium14$113
Furosemide17$69
Tramadol Hcl24$51
Methocarbamol12$51
Losartan Potassium11$37
Amlodipine Besylate12$28
Carvedilol11$22

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →